Brij Bhambi, MD

Brij Bhambi,

md


  • Office Address:

    Central Cardiology Medical Clinic
    2901 Sillect Ave. Bakersfield, CA.
    800-432-7824
    800-HEART24
    661-323-8384

  • Hospitail Appointments:

    • Bakersfield Heart Hospital
    • San Joaquin Community Hospital
    • Mercy Hospital
    • Bakersfield Memorial Hospital
    • Ridgecrest Regional Medical Center
    • chapi Valley Healthcare District


Current Status:
  • Board Member - Kern County Medical Society, 2005
  • Board Member - Bakersfield Heart Hospital, 2003-present
  • Private Practice, 1992-present
    • Central Cardiology Medical Clinic
    • Cardiac and Vascular Interventionalist
    • Consultative and General Cardiology
    • Nuclear Cardiology
  • Lead interventionalist for a large cardiology group. Practice includes heavy emphasis on complex interventions including DCA, Excimer laser, Stent Angioplasty and Peripheral Interventions.
  • Director Nuclear Lab conducting over 1400 annual nuclear studies.
  • Director of Cardiac Cath Laboratory - Bakersfield Heart Hospital, 1999-present
  • Chief of Staff - Central Cardiology Medical Clinic, 1999-present
  • Staff Cardiologist
    • Bakersfield Memorial Hospital, Bakersfield
    • San Joaquin Community Hospital, Bakersfield
    • Kern Medical Center, Bakersfield
    • Bakersfield Heart Hospital
  • Proctor for J & J intracoronary stents.
  • Proctor for Boston Scientific Rotablader Atherectomy

Certification and Licensure:
  • American Board of Internal Medicine, 2002, Interventional Cardiology
  • American Board of Internal Medicine, 2001, Cardiovascular Diseases (Re-certification, 10TH Decile)
  • American Board of Internal Medicine, 1988
  • American Board of Internal Medicine (10TH Decile)
  • Cardiovascular Diseases, 1991 (10TH Decile)
  • Internal Medicine, 1984, Sri Guru Teg Bahadur Hospital, Amritsar, Punjab, India

Education:
  • 1976-80
    • MBBS
    • Guru Nanak Dev University
    • Jalandhar, Punjab, India
  • 1974-76
    • Pre-Medical
    • Guru Nanak Dev University
    • Jalandhar, Punjab, India

Postgraduate Training:
  • 1991-92
    • Chief Cardiac Cath Lab Fellow and Interventional Cardiology Fellow
    • Cedars-Sinai Medical Center
    • Los Angeles, CA
  • 1988-91
    • Fellowship, Cardiology
    • Michael Reese Hospital and Medical Center
    • Chicago, IL
  • 1989-90
    • Molecular Cardiology
    • University of Chicago
    • Chicago, IL
  • 1987-88
    • Residency, Internal Medicine
    • Lincoln Medical Center
    • New York Medical College
    • New York, NY
  • 1986-87
    • Internship, Internal Medicine
    • Lincoln Medical Center
    • New York Medical College
    • New York, NY
  • 1982-84
    • Residency, Internal Medicine
    • Sri Guru Teg Bahadur Hospital
    • Amritsar, Punjab, India
  • 1980-81
    • Internship, Internal Medicine
    • Sri Guru Teg Bahadur Hospital
    • Amritsar, Punjab, India
Examinations:
  • 6/86 FLEX
  • 7/85 FMGEMS

Awards:
  • The Alfred Pick-Richard Langendorf Award, 1990, Michael Reese Hospital (Awarded to the most outstanding fellow)

Professional Memberships:
  • Member, Society for Cardiac Angiography and Intervention, 1994
  • Fellow, American College of Cardiology, 1994
  • Fellow, American College of Angiology, 1994
  • Member, California Medical Association, 1992
  • Member, Kern County Medical Society, 1992

Invited Lectures:
  • Excimer Laser Angioplasty: Follow up data on patients in ELCA Registry. International Congress on Interventional Cardiology, Phoenix, Arizona. February 1992
  • Laser Update: Grand Rounds, Hoag Presbyterian Hospital, Newport Beach. April 1992

Publications:
  • Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10: 77-9.
  • Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43 (abstract).
  • Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic protection withy Filter Wire and a drug eluting Taxus stent. (submitted)
  • Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous coronary interventions. JAMA. 2003; 290:1451.
  • Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C, Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
  • Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med 2002; 347: 1285.
  • Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl J Med 2002; 347: 692.
  • Sharma S, Bhambi B, Ishimori T. A better control for ICD patients? Eur Heart J 2002; 23:1972.
  • Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow during saphenous vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
  • Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P, Denny E. Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.
  • B. Bhambi, M. Eghabali: Co-Regulation of Collagen Type 1 and Transforming Growth Factor Beta in the Rat Ventricular Myocardium Following Increased Arterial Blood Pressure Induced by Norepinephrine, American Journal of Pathology, November 1991.
  • M. Eghabali, R. Tomek, R. Woods, B. Bhambi: Cardiac Fibroblasts Are Predisposed to Transform into Myocytes: Specific Effects of Transforming Growth Factor Beta 1, Proc. Natl Aca Sci February 1991.
  • M. Eghabali, R. Tomek, V. Sukhatme, C. Woods, B. Bhambi: Differential Effects of Transforming Growth Factor Beta and Phorbol Myristate Acetate on Cardiac Fibroblasts: Regulation of Fibrillar Collagen mRNA's and Expression of Immediate Early Growth Response Genes, Circulation Research, September 1991.
  • B. Bhambi, E. Morkin, S. Shroff, R. Tomek, J. Yao, M. Eghabali: Regulation of Alpha and Beta Myosin Heavy Chain Gene Expression and the Induction of Early Growth Response Genes in the Rat Ventricular Myocardium Following Norepinephrine Treatment. (Manuscript Submitted)

Abstracts:
  • B. Bhambi, E. Morkin, S. Shroff, R. Tomek, M. Eghabali: Regulation of Alpha and Beta Myosin Heavy Chain Gene Expression and the Induction of Early Growth Response Gene 1 the Rat Myocardium Following Norepinephrine Treatment, Circulation 1990; Vol 82, No. 4, 111-231, Oral Presentation, AHA, 1990 Dallas.
  • M. Eghabali, R. Tomek, C. Woods, B. Bhambi: Cardiac Fibroblasts Are Predisposed To Transform Into Myocytes: Specific Effects of Transforming Growth Factor Beta 1, Journal of Cell Biology 1990, Vol.111, Number 5, Part 2.
  • M. Eghbali, R. Tomek, C. Woods, B. Bhambi: Differential Effects of Transforming Growth Factor-Beta and Phorbol Myristate Acetate on Cardiac Fibroblasts: Regulation of Fibrillar Collagen mRNA's and Expression of Immediate Early Growth Response Genes, KEYSTONE 1991.
  • B. Bhambi, M. Eghbali: In Vivo Co-Regulation of Fibrillar Collagen Types 1 and 3, and Transforming Growth Factor Beta 1 Gee Expression in the Rat Myocardium. FASEB, 1991.